Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state
PRINT NUMBER 10521A
Email me when A 10521 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 10521. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill expands the state’s newborn screening list to include CLN2, MPS IVA, MPS VI, MPS VII, and Fabry disease. It directs the health commissioner to make tests for these conditions available within twelve months of the law’s effective date. Early detection is intended to improve outcomes for affected infants and families.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 10521
3 free questions a day, no accountHistory
- PRINT NUMBER 10521A
- AMEND AND RECOMMIT TO HEALTH
- REFERRED TO HEALTH
Sponsors
- Andrew Hevesi (D) · sponsor
- Anna Kelles
- Jo Anne Simon
- MaryJane Shimsky
- Nader Sayegh
- Nily Rozic
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 10521 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 10521 freeOr ask your AI assistant about A 10521 directly:
Add to Claude, ChatGPT or Cursor